Clinical Trials on Malignant Head and Neck Neoplasm in Belgium

Total 3455 results

Jules Bordet Institute

Completed

Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer (OC-AP-ICG-IV)

Colorectal Cancer | Peritoneal Carcinomatosis

Belgium
University Ghent
Belgian Federation Against Cancer

Completed

Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis (MMT)

Peritoneal Carcinomatosis

Belgium
Universitaire Ziekenhuizen KU Leuven
AstraZeneca

Active, not recruiting

Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer (CLIO)

Ovarian Epithelial Cancer

Belgium
University Hospital, Ghent
XEOS Medical

Recruiting

Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study (ThorPET)

Lung Neoplasms | PET-CT Specimen Imager

Belgium
University Hospital, Ghent

Completed

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

Colorectal Neoplasms

Belgium
Zimmer Biomet

Active, not recruiting

Avenir® Cemented Hip Stem - PMCF

Femoral Neck Fractures | Congenital Hip Dysplasia | Primary Osteoarthritis | Femoral Head Necrosis | Sequelae From Previous Hip Surgery | Osteotomies | Post-Traumatic Osteoarthritis of Hip

Belgium, France
Universitair Ziekenhuis Brussel

Completed

Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma (GliAvAx)

Recurrent Glioblastoma (WHO-Grade IV Glioma)

Belgium
General Hospital Groeninge

Completed

Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy (PSMLOPD)

Pancreatic Neoplasms

Belgium
Mithra Pharmaceuticals

Completed

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3) (Colvir-PhaseII)

Cervix Intraepithelial Neoplasia | Uterine Cervical Neoplasia

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology (MUSA1)

Myoma;Uterus | Sarcoma Uterus

Belgium
University Hospital, Ghent

Completed

Exclusion of Non-involved Uterus From the Target Volume in Locally Advanced Cervical Cancer (EXIT)

Uterine Cervical Neoplasms

Belgium
Cliniques universitaires Saint-Luc- Université...
Centre Georges Francois Leclerc

Completed

Simultaneous Integrated Boost (SIB)- IMRT

Carcinoma, Squamous Cell

Belgium
University Hospital, Ghent

Completed

PSMA-PET/CT for Prostate Cancer (NGP1)

Prostate Cancer

Belgium
AZ-VUB
Hoffmann-La Roche

Unknown

First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene

Lung Neoplasms | Non-Small Cell Lung Cancer | Adenocarcinoma, Bronchiolo-Alveolar

Belgium
Jules Bordet Institute

Completed

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients (OV-AP-ICG-IV)

Ovarian Cancer | Peritoneal Carcinomatosis

Belgium
Universitaire Ziekenhuizen KU Leuven
Roche Pharma AG

Unknown

Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer

Cervical Cancer

Belgium
European Lung Cancer Working Party
Jules Bordet Institute

Active, not recruiting

Has Inflammation a Significant Implication in Lung Cancer Evolution?

Lung Neoplasms

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder (MULTISIM)

Hematologic Diseases | Secondary Immune Deficiency

Belgium
Jules Bordet Institute

Recruiting

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis (FAPeCa)

Cancer | Peritoneal Carcinomatosis

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer

Prostate Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer (PART)

Prostate Cancer

Belgium
University of Liege

Completed

Mini Invasive Endomicroscopy of the Pleura for Malignancies Diagnosis

Pleural Diseases | Pleural Neoplasms

Belgium
University Hospital, Ghent

Terminated

Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer. (PROPER)

Prostate Cancer

Belgium
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)

Carcinoma, Hepatocellular | Colorectal Neoplasms | Esophageal Neoplasms | Endometrial Neoplasms | Pancreatic Ductal Adenocarcinoma | Biliary Tract Neoplasms

Israel, United States, Australia, Belgium, Chile, France, Korea, Republic of, Netherlands, Spain, New Zealand
University Hospital, Ghent

Completed

Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery

Prostate Cancer

Belgium
University Hospital, Ghent

Completed

Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer (Hypofraction)

Prostate Cancer

Belgium
European Organisation for Research and Treatment...

Completed

Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer

Prostate Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Terminated

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Neuroendocrine Tumors | Neural Crest Tumor

Belgium
Erasme University Hospital
AZ Sint-Jan AV; Cliniques universitaires Saint-Luc- Université Catholique de... and other collaborators

Completed

PAtient-PHYsician Relationship Assessment (PAPHYRA)

Hepatocellular Carcinoma

Belgium
BTG International Inc.

Terminated

Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma

Hepatocellular Carcinoma

Belgium
Jules Bordet Institute

Completed

Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Metastases (OvEpiLyPath)

Carcinomatosis, Peritoneal

Belgium
University Hospital, Ghent
Universitaire Ziekenhuizen KU Leuven; University Hospital, Antwerp; Cliniques...

Recruiting

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma (GLITCA)

Liver Transplantation | Hepatocellular Carcinoma | Prognostic Biomarker | Diagnostic Biomarker

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib

Gastrointestinal Stromal Tumors

Belgium
Jules Bordet Institute

Recruiting

Multidisciplinary Approach to Fatigue

Breast Cancer | Germ Cell Tumor

Belgium
EuMelaReg gGmbH

Recruiting

Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients With Advanced NMSC

Basal Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients

Hiv | Human Papilloma Virus | Organ Transplants

Belgium
University Hospital, Ghent
Farmafyt

Completed

Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation

Prostate Cancer

Belgium
Universitair Ziekenhuis Brussel

Not yet recruiting

A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma (NEO-GLITIPNI)

Recurrent Glioblastoma

Belgium
University Hospital, Ghent

Active, not recruiting

Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years (HAI-5-III)

Breastcancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study

Breast Neoplasms | Radiation

Belgium
University Hospital, Ghent

Completed

EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer

Lung Cancer

Belgium
University Hospital, Ghent
Ipsen

Completed

Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma

Rectal Carcinoma

Belgium
University Hospital, Ghent

Completed

Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) (IMPRINT)

Prostatic Neoplasms | Prostate Cancer | Prostate Adenocarcinoma

Belgium
Erasme University Hospital

Completed

Added Value of Cone Beam CT Guidance to Electromagnetic Navigation Bronchoscopy for the Diagnosis of Pulmonary Nodule.

Lung Cancer | Pulmonary Disease

Belgium
University Hospital, Ghent
University Ghent

Completed

Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)

Primary Liver Cancer

Belgium
European Organisation for Research and Treatment...

Terminated

Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery

Lung Cancer

Belgium
University Hospital, Ghent
Takeda

Completed

Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.

Prostate or Bladder Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; University Hospital, Antwerp; NETwerk, Belgium

Completed

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Neuroendocrine Tumors

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Neuroendocrine Tumors

Belgium
Universitair Ziekenhuis Brussel

Active, not recruiting

Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC) (myDCTV)

Melanoma

Belgium

Clinical Trials on Malignant Head and Neck Neoplasm in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations